Kamran Alam
2015 - Aquinox Pharmaceuticals
In 2015, Kamran Alam earned a total compensation of $490K as Chief Financial Officer and Vice President, Finance at Aquinox Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $66,529 |
|---|---|
| Option Awards | $233,400 |
| Salary | $190,083 |
| Total | $490,012 |
Alam received $233.4K in option awards, accounting for 48% of the total pay in 2015.
Alam also received $66.5K in non-equity incentive plan and $190.1K in salary.
Rankings
In 2015, Kamran Alam's compensation ranked 10,912th out of 13,638 executives tracked by ExecPay. In other words, Alam earned more than 20.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,912 out of 13,638 | 20th |
Division Manufacturing | 4,167 out of 5,190 | 20th |
Major group Chemicals And Allied Products | 1,529 out of 1,854 | 18th |
Industry group Drugs | 1,260 out of 1,528 | 18th |
Industry Pharmaceutical Preparations | 983 out of 1,182 | 17th |
Source: SEC filing on March 26, 2018.
Alam's colleagues
We found three more compensation records of executives who worked with Kamran Alam at Aquinox Pharmaceuticals in 2015.
News
Taysha Gene Therapies CEO Sean Nolan's 2023 pay slips 20% to $1.5M
April 18, 2024
Taysha Gene Therapies CEO RA Session's 2022 pay falls 57% to $2M
May 8, 2023
Taysha Gene Therapies CEO RA Session's 2021 pay slips 3% to $4.6M
April 28, 2022
Inotek Pharmaceuticals CEO Gaurav Shah's 2019 pay falls 39% to $3.9M
April 24, 2020
Aquinox Pharmaceuticals CEO Jonathan Drachman receives $3.8M in 2019
March 24, 2020
Aquinox Pharmaceuticals CEO David Main's 2018 pay jumps 39% to $4.2M
October 2, 2019